PATENT CLAIM ANALYSIS

Application Number: 16193859
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "269000"]

Abstract:
The invention relates to a product containing the compound of formula (I) below (I) or a pharmaceutically acceptable salt of this compound, in combination with at least one compound having PDE5-inhibitory properties, or a pharmaceutically acceptable salt thereof, for therapeutic use, simultaneously, separately or over a period of time, in the treatment of a disease wherein vasoconstriction is involved.

Claim (Index 4):
A product according to  claim 2 , wherein the compound having PDE5-inhibitory properties is sildenafil.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 98.0
- Lexical Diversity: 1.52174
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12439290', '14335657', '13058639', '14873787', '13738232']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7679364869566497
- 35 USC 102 Novelty (BERT): 0.5963765858335349
- Combined Prediction Score: 0.7507804968443382
- Mean Citation Score: 292.555272
- Max Citation Score: 497.48123
- Similarity Product: 477.2569821009283

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test